“LNP provides a compelling approach to deliver on the promise of gene therapy, and our leadership position in the LNP space is well established,” said Pete ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercebiotech.com/biotech/genevant-pens-303m-biobucks-pact-takeda-aiming-at-rare-liver-diseases-using-gene-therapy&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNF0NZK4btkb3yugjJC0kAgh7y11Pw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.